News

Obama's War On Weed: White House Launches Crackdown On Medical Marijuana

Article Image

SAN FRANCISCO -- Three years on, not a single Wall Street banker has been prosecuted after a financial crisis rooted in rampant fraud brought the global economy to its knees. President Obama's Department of Justice has more dangerous miscreants to worry about: medical marijuana shop owners.

The DoJ has launched an assault on medical pot dispensaries, vowing to shut down establishments licensed and regulated by state and local governments, in a reversal of an earlier policy, based on an Obama campaign promise to leave the shops alone as long as they followed state law.

And while major corporations have managed to get their federal tax bills down to zero, the IRS has determined that pot clinics can't deduct salaries, rent, the cost of bud or other operating expenses on their tax returns. If a business can't deduct those expenses, its tax bill almost always winds up exceeding even its profits.

Despite a previous DoJ memo that targeting medical marijuana is an inefficient use of time and resources, this past Friday morning, four California-based U.S. Attorneys and their staffs gathered in front of Sacramento's capitol building to announce an aggressive new crackdown on medical marijuana operations throughout the state -- this one aimed at the landlords who manage buildings in which dispensaries operate.

Detailing an industry that has "swelled to include numerous drug-trafficking enterprises," the federal officials warned they would be taking action against dozens of dispensaries they accused of abusing California's medical marijuana laws.

"The California marijuana industry is not about providing medicine to the sick," said U.S. Attorney Laura E. Duffy. "It's a pervasive for-profit industry that violates federal law."

Meanwhile, medical marijuana in California is experiencing a renaissance. While the U.S. attorneys held their press conference, the West Coast Cannabis Expo had just opened its doors in San Francisco, drawing pot enthusiasts from across the state for the ultimate celebration of all things weed.

WeedMaps Media Finalizes Licensing Agreement With SC Laboratories and Launches Cannabis Testing

  
SOURCE: General Cannabis, Inc.

NEWPORT BEACH, CA--(Marketwire - Sep 1, 2011) - General Cannabis, Inc. (OTCQX: CANA) (PINKSHEETS: CANA), a technology-based Internet marketing services company, today announced that WeedMaps Media has finalized a licensing agreement with SC Laboratories for cannabis testing services. SC Laboratories will leverage WeedMaps' extensive marketing portal to offer medicinal cannabis patients relevant information about the quality and strength of their medicine.

"Through this agreement, WeedMaps and SC Laboratories will make testing the new standard in the cannabis industry. Patients can now go to WeedMaps.com to select the best tested medicine specifically for their own medicinal needs, in addition to finding local dispensaries and the best deals," said Doug Francis, President and Chief Strategy Officer of General Cannabis. "Quality matters, especially for patients with acute pain and discomfort, and now it can be quantifiably measured by turning to SC Labs' Test results on WeedMaps.com."

Josh Wurzer, Laboratory Director for SC Laboratories, commented, "WeedMaps and SC Labs will seek to educate and move our industry toward a higher standard of service, where potency testing, standardized dosing, and quality assurance testing for pesticides, fungicides and microbiological contamination become widely accepted and acknowledged industry standards."

Among the first independent analytical institutions to recognize the importance of promoting cannabis safety through education, testing and certification, SC Laboratories provides a comprehensive testing array for pesticide and microbiological contamination, as well as strain potency analysis. SC Laboratories utilizes High Performance Liquid Chromatography with a Diode Array Detector (HPLC-DAD,) for potency testing. HPLC has become the standard for potency testing over the older GC technology. HPLC does not use heat, therefore making it possible to determine the levels of acidic cannabinoids (the major constituents of raw medical cannabis) as they are found in the plant. Accurate cannabinoid profiling allows patients a better gauge for standardizing dosage.

About General Cannabis

General Cannabis, Inc. (OTCQX: CANA) (PINKSHEETS: CANA), a technology-based Internet marketing services company, offers customers an integrated suite of services including media, technology, marketing and information. Founded in 2010, General Cannabis is headquartered in Newport Beach, California. www.GeneralCannabis.com

Safe Harbor Notice

Certain statements contained herein are "forward-looking statements" (as defined in the Private Securities Litigation Reform Act of 1995). General Cannabis, Inc. cautions that statements made in this news release constitute forward-looking statements and makes no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. These statements may address issues that involve significant risks, uncertainties, estimates and assumptions made by management. Actual results could differ materially from current projections or implied results. General Cannabis, Inc. undertakes no obligation to revise these statements following the date of this news release.

 

SC Labs Partners with WeedMaps.com

SC Laboratories is pleased to announce our partnership with WeedMaps.com to offer cannabis testing services.  Recentely, WeedMapsTV visited the laboratory to take a look around.  

 

Too Many Mouldy Joints: Marijuana and Chronic Pulmonary Aspergillosis

By Yousef Gargani,1 Paul Bishop,2 and David W. Denning1

Chronic pulmonary aspergillosis is a progressive debilitating disease with multiple underlying pulmonary diseases described. Here we report the association of chronic pulmonary aspergillosis and long term marijuana smoking in 2 patients and review the literature related to invasive and allergic aspergillosis.

Introduction
Marijuana is the most commonly used illicit substance in the UK and many other western countries, despite it being a class B drug. It is available legally in some localities, including the Netherlands. There is a well known link between marijuana use and schizophrenia. There is currently uncertainty about any causal association between marijuana use and lung cancer as the effects of concomitant tobacco smoking amongst these users confound analyses. A small number of cases of various forms of aspergillosis have been associated with marijuana smoking, but the association appears to be uncommon.19
We present 2 cases of chronic pulmonary aspergillosis (CPA) associated with extensive medicinal use of marijuana, and summarise the literature linking all forms of aspergillosis and marijuana use.